$KLTR
KALTURA INC Stock $kltr

$kltr Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000117891322000830 Filed on February 25, 2022

Income Statement

Concept	2021 Q4	2021
Revenue	$42.72M	$165.0M
YoY Change		37.01%
Cost Of Revenue	$15.94M	$62.31M
YoY Change		30.73%
Gross Profit	$26.77M	$102.7M
YoY Change		41.12%
Gross Profit Margin	62.68%	62.24%
Selling, General & Admin	$25.88M	$85.28M
YoY Change		64.96%
% of Gross Profit	96.66%	83.03%
Research & Development	$13.33M	$48.38M
YoY Change		63.61%
% of Gross Profit	49.77%	47.1%
Depreciation & Amortization	$617.0K	$2.412M
YoY Change		-68.58%
% of Gross Profit	2.3%	2.35%
Operating Expenses	$39.20M	$135.4M
YoY Change		66.59%
Operating Profit	-$12.43M	-$32.68M
YoY Change		284.91%
Interest Expense	-$1.550M	$2.979M
YoY Change		-27.18%
% of Operating Profit
Other Income/Expense, Net	-$124.0K	-$20.11M
YoY Change		-56.97%
Pretax Income	-$14.11M	-$52.78M
YoY Change		-4.4%
Income Tax	$1.821M	$6.570M
% Of Pretax Income
Net Earnings	-$15.93M	-$59.35M
YoY Change		1.0%
Net Earnings / Revenue	-37.28%	-35.97%
Basic Earnings Per Share		-$0.95
Diluted Earnings Per Share	-$123.1K	-$835.1K
COMMON SHARES
Basic Shares Outstanding		71.07M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$143.9M	$143.9M
YoY Change		419.47%
Cash & Equivalents	$143.9M	$143.9M	$27.71M
Short-Term Investments
Other Short-Term Assets	$676.0K	$14.19M	$56.00K
YoY Change	1107.14%	64.66%
Inventory
Prepaid Expenses	$3.858M		$2.086M
Receivables	$17.51M	$17.51M	$17.13M
Other Receivables	$576.0K	$0.00	$335.0K
Total Short-Term Assets	$175.6M	$175.6M	$53.46M
YoY Change	228.55%	228.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.503M	$9.503M	$4.147M
YoY Change	129.15%	129.15%
Goodwill	$11.07M		$11.07M
YoY Change	0.0%		18.0%
Intangibles	$1.909M		$2.835M
YoY Change	-32.66%
Long-Term Investments
YoY Change
Other Assets	$2.543M	$25.16M	$3.564M
YoY Change	-28.65%	29.44%
Total Long-Term Assets	$47.65M	$47.65M	$37.49M
YoY Change	27.08%	27.08%
TOTAL ASSETS
Total Short-Term Assets	$175.6M	$175.6M	$53.46M
Total Long-Term Assets	$47.65M	$47.65M	$37.49M
Total Assets	$223.3M	$223.3M	$90.95M
YoY Change	145.5%	145.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.480M	$6.480M	$5.045M
YoY Change	28.44%	28.44%
Accrued Expenses	$7.240M	$36.98M	$4.687M
YoY Change	54.47%	34.33%
Deferred Revenue	$51.69M		$47.69M
YoY Change	8.4%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.794M	$2.941M	$1.000M
YoY Change	179.4%	7.41%
Total Short-Term Liabilities	$98.09M	$98.09M	$82.99M
YoY Change	18.18%	18.18%
LONG-TERM LIABILITIES
Long-Term Debt	$35.80M	$35.80M	$47.16M
YoY Change	-24.1%	-24.33%
Other Long-Term Liabilities	$2.185M	$4.138M	$2.706M
YoY Change	-19.25%	-93.24%
Total Long-Term Liabilities	$39.93M	$39.93M	$108.5M
YoY Change	-63.2%	-63.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$98.09M	$98.09M	$82.99M
Total Long-Term Liabilities	$39.93M	$39.93M	$108.5M
Total Liabilities	$138.0M	$138.0M	$191.5M
YoY Change	-27.93%	-27.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$322.6M		-$263.3M
YoY Change	22.54%
Common Stock	$412.8M		$8.390M
YoY Change	4819.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.881M		$4.881M
YoY Change	0.0%
Treasury Stock Shares	7.685M shares		7.685M shares
Shareholders Equity	$85.27M	$85.27M	-$260.7M
YoY Change
Total Liabilities & Shareholders Equity	$223.3M	$223.3M	$90.95M
YoY Change	145.5%	145.5%

Cashflow Statement

Concept	2021 Q4	2021
OPERATING ACTIVITIES
Net Income	-$15.93M	-$59.35M
YoY Change		1.0%
Depreciation, Depletion And Amortization	$617.0K	$2.412M
YoY Change		-68.58%
Cash From Operating Activities	-$10.74M	-$22.11M
YoY Change		-480.94%
INVESTING ACTIVITIES
Capital Expenditures	-$1.587M	$1.876M
YoY Change		67.8%
Acquisitions
YoY Change
Other Investing Activities	$115.0K	$757.0K
YoY Change		97.65%
Cash From Investing Activities	-$1.472M	-$5.242M
YoY Change		90.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-23.56M	$143.4M
YoY Change		-7862.21%
NET CHANGE
Cash From Operating Activities	-10.74M	-$22.11M
Cash From Investing Activities	-1.472M	-$5.242M
Cash From Financing Activities	-23.56M	$143.4M
Net Change In Cash	-35.78M	$116.0M
YoY Change		9480.18%
FREE CASH FLOW
Cash From Operating Activities	-$10.74M	-$22.11M
Capital Expenditures	-$1.587M	$1.876M
Free Cash Flow	-$9.153M	-$23.99M
YoY Change		-611.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2322000	USD
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Trading Symbol TradingSymbol	KLTR
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2019Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	606000	USD
CY2021	dei	Auditor Firm AuditorFirmId	1281
CY2021Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	kltr	Income Tax Reconciliation Exchange Rate Differences IncomeTaxReconciliationExchangeRateDifferences	-100000	USD
CY2020	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2000000	USD
CY2021	dei	Security12b Title Security12bTitle	Common stock
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127065210	shares
CY2021	dei	Auditor Name AuditorName	KOST FORER GABBAY & KASIERER
CY2021	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2021Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	147000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1738000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	18349000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	11251000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	56780000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	160112000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	157500000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7685190	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7685190	shares
CY2020Q4	kltr	Treasury Shares Par Value Per Share TreasurySharesParValuePerShare	0.0001
CY2021Q4	kltr	Receivables On Account Of Stock ReceivablesOnAccountOfStock	0	USD
CY2020Q4	kltr	Receivables On Account Of Stock ReceivablesOnAccountOfStock	882000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27144000	USD
CY2021	us-gaap	Other General Expense OtherGeneralExpense	1724000	USD
CY2020	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2019	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-46721000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	8241000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	11934000	USD
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	9749000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-67592000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-70697000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25321000	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.95
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	2.83
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.11
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	71073052	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24939901	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22754499	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-196035000	USD
CY2019	kltr	Cumulative Effect Adjustment For Adoption Of Asu CumulativeEffectAdjustmentForAdoptionOfAsu	8606000	USD
CY2021	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	1569000	USD
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2020	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2021	us-gaap	Preferred Stock Redemption Discount PreferredStockRedemptionDiscount	0	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	635000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	161261000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	147000	USD
CY2019	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	9749000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15572000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-210281000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5114000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	280000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3057000	USD
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2578000	USD
CY2020	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	2641000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-58763000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-260656000	USD
CY2021	kltr	Preferred Stock Value Issued In Conversion Of Warrants PreferredStockValueIssuedInConversionOfWarrants	0	USD
CY2021	kltr	Loan Forgiveness LoanForgiveness	882000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	155598000	USD
CY2021	kltr	Stock Issued During Period Value Conversion Of Warrants To Common Stock StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock	70677000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17065000	USD
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	1367000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-59351000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	85274000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-59351000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-58763000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15572000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4490000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	2322000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3290000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	15046000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	41505000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5300000	USD
CY2021	kltr	Non Cash Interest Expenses NonCashInterestExpenses	331000	USD
CY2020	kltr	Non Cash Interest Expenses NonCashInterestExpenses	263000	USD
CY2019	kltr	Non Cash Interest Expenses NonCashInterestExpenses	407000	USD
CY2021	kltr	Non Cash Expenses With Respect To Stockholders Loans NonCashExpensesWithRespectToStockholdersLoans	882000	USD
CY2020	kltr	Non Cash Expenses With Respect To Stockholders Loans NonCashExpensesWithRespectToStockholdersLoans	0	USD
CY2019	kltr	Non Cash Expenses With Respect To Stockholders Loans NonCashExpensesWithRespectToStockholdersLoans	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	757000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6159000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	39000	USD
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6275000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2352000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5886000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1435000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	54000	USD
CY2019	kltr	Increase In Deferred Contract Acquisition And Fulfillment Costs IncreaseInDeferredContractAcquisitionAndFulfillmentCosts	6590000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3886000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2004000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4964000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1517000	USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1343000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5804000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	370000	USD
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2020	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	383000	USD
CY2019	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2239000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	757000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2019	us-gaap	Payments For Software PaymentsForSoftware	249000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	145000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	162000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	244000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2732000	USD
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	160425000	USD
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2019	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2021	kltr	Payment Related To Conversion Of Redeemable Convertible Preferred Stock Upon Initial Public Offering PaymentRelatedToConversionOfRedeemableConvertiblePreferredStockUponInitialPublicOffering	1569000	USD
CY2020	kltr	Payment Related To Conversion Of Redeemable Convertible Preferred Stock Upon Initial Public Offering PaymentRelatedToConversionOfRedeemableConvertiblePreferredStockUponInitialPublicOffering	0	USD
CY2019	kltr	Payment Related To Conversion Of Redeemable Convertible Preferred Stock Upon Initial Public Offering PaymentRelatedToConversionOfRedeemableConvertiblePreferredStockUponInitialPublicOffering	0	USD
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	41915000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1211000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	300000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	116016000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	4298000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	143368000	USD
CY2019	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2971000	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2021	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1717000	USD
CY2020	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2354000	USD
CY2019	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2818000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	147000	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5188000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	106000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2062000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29206000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27144000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	142000	USD
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2020	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2019	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	98000	USD
CY2021	kltr	Stock Issued During Period Value Conversion Of Warrants To Common Stock StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock	70677000	USD
CY2020	kltr	Stock Issued During Period Value Conversion Of Warrants To Common Stock StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock	0	USD
CY2019	kltr	Stock Issued During Period Value Conversion Of Warrants To Common Stock StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock	0	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	161261000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2020	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	3799000	USD
CY2019	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2021	kltr	Unpaid Deferred Offering Costs UnpaidDeferredOfferingCosts	0	USD
CY2020	kltr	Unpaid Deferred Offering Costs UnpaidDeferredOfferingCosts	976000	USD
CY2019	kltr	Unpaid Deferred Offering Costs UnpaidDeferredOfferingCosts	0	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	1073000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26538000	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17111000	USD
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1221000	USD
CY2021	kltr	Reclassification Of Warrant To Common Stocks To Equity ReclassificationOfWarrantToCommonStocksToEquity	0	USD
CY2020	kltr	Reclassification Of Warrant To Common Stocks To Equity ReclassificationOfWarrantToCommonStocksToEquity	3057000	USD
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	1149000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	15046000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	41505000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	56780000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	56780000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:67.5pt"> </td> <td style="width:18pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">a.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Use of Estimates:</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, income tax uncertainties, stock-based compensation cost, fair value measurement of warrants and accretion of redeemable stocks (both prior to the IPO), fair value and useful life of intangible assets, as well as in estimates used in applying the revenue recognition policy. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Due to the Coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require a material update to its estimates or judgments or an adjustment of the carrying value of its assets or liabilities as of December 31, 2021.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">While there was not a material impact to the Company’s consolidated financial statements as of and for the year ended December 31, 2021, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 and its variants that could result in material impacts to the Company’s consolidated financial statements in future reporting periods.</span></span></div> </div>
CY2021Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0450	pure
CY2021	kltr	Stock Issued During Period Shares Conversion Of Warrants To Common Stock StockIssuedDuringPeriodSharesConversionOfWarrantsToCommonStock	7067699	shares
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	3937000	USD
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	2565000	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	2212000	USD
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.065	pure
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3108000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2061000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1722000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	2156000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	56780000	USD
CY2020	kltr	Stock Issued During Period Value Conversion Of Warrants To Common Stock StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock	0	USD
CY2021	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	4838000	USD
CY2020	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1893000	USD
CY2019	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	249000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	5057000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	3143000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:67.5pt"> </td> <td style="width:18pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">y.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Concentration of Credit Risks:</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash and trade receivables.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The majority of the Company's and its subsidiaries' cash and cash equivalents and restricted cash are invested with major banks in Israel, the United Kingdom and the United States. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. However, in general, these investments may be redeemed upon demand and therefore bear minimal risk.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Company's trade receivables are geographically dispersed and derived from sales to customers mainly in the United States, Europe and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures.</span></span></div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"> </div> <div/> <div style="line-height:1.25"> <div style="line-height:1.25"> <div style="line-height:1.25;font-weight:bold"> </div> <div style="line-height:1.25;font-weight:bold"> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:normal"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Major customer data as a percentage of total revenues:</span></span></div> </div> <div style="line-height:1.25;font-weight:bold"> </div> </div> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The following table sets forth a customer that represented 10% or more of the Company’s total revenue in each of the periods set forth below:</span></span></div> <div> <div style="line-height:1.25"> </div> <div style="margin-left:85pt"> <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:100%"> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended</span></span></div> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2019</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:top" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Customer A (Media and Telecom)</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="-sec-ix-hidden:Fxbrl_20220223130257469"></span></span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11.60</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12.01</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div> </td> </tr> </table> </div> <div> </div> <div style="text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">) Represents an amount that is lower than 10% of the Company’s total revenue.</span></span></div> </div> </div>
CY2021	kltr	Increase In Total Assets And Liabilities Result Of Recognition Of Operating Lease Right Of Use Assets And Operating Lease Liabilities IncreaseInTotalAssetsAndLiabilitiesResultOfRecognitionOfOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities	823000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	1082000	USD
CY2021Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	153000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	165000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3858000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2086000	USD
CY2021Q4	kltr	Receivables From Government Institutions ReceivablesFromGovernmentInstitutions	576000	USD
CY2020Q4	kltr	Receivables From Government Institutions ReceivablesFromGovernmentInstitutions	335000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	564000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	292000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	112000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5110000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2769000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12159000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7246000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2656000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3099000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9503000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4147000	USD
CY2021	us-gaap	Depreciation Depreciation	1407000	USD
CY2020	us-gaap	Depreciation Depreciation	2791000	USD
CY2019	us-gaap	Depreciation Depreciation	3860000	USD
CY2021	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	1849000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3969000	USD
CY2020	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	16886000	USD
CY2019	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2543000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3564000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	422000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	644000	USD
CY2021Q4	kltr	Severance Pay Fund SeverancePayFund	1968000	USD
CY2020Q4	kltr	Severance Pay Fund SeverancePayFund	1673000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8099000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6190000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1909000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8020000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5185000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2835000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1005000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	917000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	630000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	666000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	554000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	478000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	148000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	50000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	13000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1909000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	595000	USD
CY2021Q4	kltr	Capitalized Intangible Assets Against Respective Liability CapitalizedIntangibleAssetsAgainstRespectiveLiability	79000	USD
CY2020Q4	kltr	Capitalized Intangible Assets Against Respective Liability CapitalizedIntangibleAssetsAgainstRespectiveLiability	163000	USD
CY2019Q4	kltr	Capitalized Intangible Assets Against Respective Liability CapitalizedIntangibleAssetsAgainstRespectiveLiability	202000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	9381000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	9381000	USD
CY2021	kltr	Debt Instrument Floor Rate DebtInstrumentFloorRate	0.0100	pure
CY2021	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0350	pure
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1689000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	11070000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2021Q4	us-gaap	Goodwill Goodwill	11070000	USD
CY2021	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	Borrowings under the Credit Facilities are subject to interest, determined as follows: (a) Eurodollar loans accrue interest at a rate per annum equal to the Eurodollar rate plus a margin of 3.50% (the Eurodollar rate is calculated based on the Credit Agreement, subject to a 1.00% floor, divided by 1.00 minus the maximum effective reserve percentage for Eurocurrency funding), and (b) Alternate Base Rate (“ABR”) loans accrue interest at a rate per annum equal to the ABR plus a margin of 2.50% (ABR is equal to the highest of (i) the prime rate and (ii) the Federal Funds Effective Rate plus 0.50%, subject to a 2.00% floor). As of December 31, 2021, the current rate of interest under the Credit Facilities was equal to a rate per annum of 4.50%, consisting of the 1.00% floor and the margin of 3.50%.
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	30000000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7240000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4687000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	9525000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4984000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1584000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1580000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	18349000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	11251000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1317000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	788000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	806000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	862000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	919000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	548000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5240000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2278000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2152000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2121000	USD
CY2021Q4	us-gaap	Area Of Land AreaOfLand	13815000
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	13427000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	12166000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	22585000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	13000000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	14250000	USD
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	75428000	USD
CY2021Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	147000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.57	pure
CY2016Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7146490	shares
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0001
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	15046000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	41505000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5300000	USD
CY2021	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	65000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8751000	USD
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2020Q4	kltr	Temporary Equity Shares Issued And Outstanding TemporaryEquitySharesIssuedAndOutstanding	16823100	shares
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	11811000	USD
CY2019	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2019	kltr	Reclassification Of Warrant To Common Stocks To Equity ReclassificationOfWarrantToCommonStocksToEquity	0	USD
CY2020	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	0	USD
CY2019	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	0	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5300000	USD
CY2021	kltr	Stock Issued During Period Value Conversion Of Warrants To Common Stock StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock	70677000	USD
CY2019	kltr	Stock Issued During Period Value Conversion Of Warrants To Common Stock StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock	0	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17111000	USD
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.38
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32702963	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.45
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.80
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.13
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	13152000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3615000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2377000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8842000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	837000	USD
CY2020	kltr	Weighted Average Fair Value Of Market Based Awards Granted Per Option WeightedAverageFairValueOfMarketBasedAwardsGrantedPerOption	2.26
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5225000	USD
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.02	pure
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	7937455	shares
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	38894000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	17906181	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	32778000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5437000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	968385	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31981404	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.25
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.86
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.98
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100495000	USD
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	863041	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.53
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.59
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y9M18D
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	17012609	shares
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	187346000	USD
CY2021Q1	kltr	Number Of Warrants Converted NumberOfWarrantsConverted	31414	shares
CY2021Q1	kltr	Number Of Preferred Shares Issued In Conversion Of Warrants NumberOfPreferredSharesIssuedInConversionOfWarrants	27011	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2552985	shares
CY2020	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	57000	USD
CY2019	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	43000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	6505000	USD
CY2020	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	3496000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	62275000	USD
CY2021Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4.5	pure
CY2019	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	1561000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6570000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3553000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17065000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5114000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2322000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	75259000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	67540000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	20882000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-22478000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-12330000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-6914000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52781000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55210000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13968000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1604000	USD
CY2020	kltr	Income Tax Reconciliation Exchange Rate Differences IncomeTaxReconciliationExchangeRateDifferences	-113000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	76950000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019	kltr	Income Tax Reconciliation Exchange Rate Differences IncomeTaxReconciliationExchangeRateDifferences	-133000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	60905000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	688000	USD
CY2021Q4	kltr	Disallowed Business Interest Expense DisallowedBusinessInterestExpense	4404000	USD
CY2020Q4	kltr	Disallowed Business Interest Expense DisallowedBusinessInterestExpense	3571000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2448000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2337000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	83802000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	66813000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	75051000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61588000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8751000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5225000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	696000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	664000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	6607000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	4561000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1448000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52781000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55210000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13968000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-11084000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-11594000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-2933000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	403000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	269000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	235000	USD
CY2021	kltr	Effective Income Tax Rate Reconciliation Remeasurement Of Warrants To Fair Value Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfWarrantsToFairValueAmount	3160000	USD
CY2020	kltr	Effective Income Tax Rate Reconciliation Remeasurement Of Warrants To Fair Value Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfWarrantsToFairValueAmount	8716000	USD
CY2019	kltr	Effective Income Tax Rate Reconciliation Remeasurement Of Warrants To Fair Value Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfWarrantsToFairValueAmount	1113000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	3651000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	1081000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	517000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	13232000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3300000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2636000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3700000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	320000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1786000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	319000	USD
CY2020	kltr	Financial Expenses FinancialExpenses	46739000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	108000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-150000	USD
CY2019	kltr	Financial Expenses FinancialExpenses	11322000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6570000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3553000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1604000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.23	pure
CY2021Q4	kltr	Alternative Tax Benefits And Income Tax Liability AlternativeTaxBenefitsAndIncomeTaxLiability	152000	USD
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	2355000	USD
CY2020Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1803000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20106000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2006000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	256000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	403000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2665000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	311000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	887000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3863000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	107000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	738000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4494000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4494000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	171000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	90000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	97000	USD
CY2021	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	5000	USD
CY2020	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	18000	USD
CY2019	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	133000	USD
CY2021	kltr	Financial Income FinancialIncome	5000	USD
CY2020	kltr	Financial Income FinancialIncome	18000	USD
CY2019	kltr	Financial Income FinancialIncome	133000	USD
CY2021	kltr	Bank Fees BankFees	530000	USD
CY2020	kltr	Bank Fees BankFees	370000	USD
CY2019	kltr	Bank Fees BankFees	326000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	15046000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	41505000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5300000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-46721000	USD
CY2021	us-gaap	Interest Expense InterestExpense	2979000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11189000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20106000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6570000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-59351000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	120440000	USD
CY2020	us-gaap	Gross Profit GrossProfit	72775000	USD
CY2019	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	106000	USD
CY2021	kltr	Financial Expenses FinancialExpenses	20111000	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	55581779	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41118857	shares
CY2020	us-gaap	Interest Expense InterestExpense	4091000	USD
CY2019	us-gaap	Interest Expense InterestExpense	4298000	USD
CY2021	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	1136000	USD
CY2020	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	666000	USD
CY2019	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	1292000	USD
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	420000	USD
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	107000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-59351000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-58763000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15572000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	8241000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	11934000	USD
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	9749000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-67592000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-70697000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25321000	USD
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	71073052	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24939901	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22754499	shares
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.95
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	2.83
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.11
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	37627380	shares
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11189000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	81264000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	165016000	USD
CY2021	us-gaap	Gross Profit GrossProfit	102702000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	135377000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1604000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-46721000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3553000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15572000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-58763000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	97349000	USD
CY2019	us-gaap	Gross Profit GrossProfit	61731000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	64510000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	165016000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	120440000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	97349000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9503000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4147000	USD
CY2021	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	In June 2019, the Company entered into an agreement with a certain shareholder under which the shareholder received a one-year subscription to use the Company's software.

Files In Submission

Name	View Source	Status
0001178913-22-000830-index-headers.html	Edgar Link	pending
0001178913-22-000830-index.html	Edgar Link	pending
0001178913-22-000830.txt	Edgar Link	pending
0001178913-22-000830-xbrl.zip	Edgar Link	pending
exhibit_10-19.htm	Edgar Link	pending
exhibit_10-20.htm	Edgar Link	pending
exhibit_10-3.htm	Edgar Link	pending
exhibit_21-1.htm	Edgar Link	pending
exhibit_23-1.htm	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
exhibit_4-4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image00001.jpg	Edgar Link	pending
image1.jpg	Edgar Link	pending
kltr-20211231.xsd	Edgar Link	pending
kltr-20211231_cal.xml	Edgar Link	unprocessable
kltr-20211231_def.xml	Edgar Link	unprocessable
kltr-20211231_lab.xml	Edgar Link	unprocessable
kltr-20211231_pre.xml	Edgar Link	unprocessable
kltr_img01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk2227356.htm	Edgar Link	pending
zk2227356_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KLTR
KALTURA INC Stock $kltr

2021 Q4 Form 10-K Financial Statement

#000117891322000830 Filed on February 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLTR KALTURA INC Stock $kltr

2021 Q4 Form 10-K Financial Statement

#000117891322000830 Filed on February 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLTR
KALTURA INC Stock $kltr